Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Imfinzi plus chemotherapy reduced risk of death by 20% in 1st-line advanced biliary tract cancer
-
Imfinzi plus tremelimumab demonstrated unprecedented survival in 1st-line unresectable liver cancer with 31% of patients alive at three years
-
Enhertu granted Priority Review in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen
-
AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data at ASCO GI and GU
-
AstraZeneca and Scorpion Therapeutics enter agreement to discover, develop and commercialise novel cancer treatments against ‘undruggable’ targets
-
New Vaxzevria data further support its use as third dose booster
-
template 2022
-
AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006
-
Transfer of global rights for Eklira and Duaklir to Covis Pharma completed
-
AstraZeneca and Ionis close agreement to develop and commercialise eplontersen
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
